Annual and Interim Reports
Annual General Meeting
Conflict Minerals Disclosure
Quarterly Results and Presentations
WHO WE ARE
Areas of Focus
How We Operate
Our R&D Strategy
Investigator Initiated Research (IIR)
Collaborative Research (CR)
The global leader in rare diseases is now part of Takeda, a leading biopharmaceutical company bringing better health and a brighter future to people worldwide.
By following this link you will be leaving a Shire controlled website for a third party website. Please note that Shire is not responsible or liable for any third party website and the website may not be appropriate for all audiences.